Avalo Therapeutics (AVTX) Gross Margin Growth (3y) (2020 - 2024)
Avalo Therapeutics (AVTX) Gross Margin Growth (3y) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 722.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -191.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -162.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -40.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -21,949.00 |
| Dec 31, 2023 | 4,398.00 |
| Sep 30, 2023 | -9,773.00 |
| Jun 30, 2023 | -10,428.00 |
| Mar 31, 2023 | -11,360.00 |
| Dec 31, 2022 | -4,300.00 |
| Sep 30, 2022 | 248.00 |
| Jun 30, 2022 | -4,479.00 |
| Mar 31, 2022 | -3,217.00 |
| Dec 31, 2021 | -15,976.00 |
| Sep 30, 2021 | 909.00 |
| Jun 30, 2021 | 2,726.00 |
| Mar 31, 2021 | 299.00 |
| Dec 31, 2020 | 2,799.00 |
| Sep 30, 2020 | -693.00 |
| Jun 30, 2020 | -583.00 |
| Mar 31, 2020 | -240.00 |